Gregory Demske > Goodwin > Washington DC, United States > Lawyer Profile
Goodwin Offices
1900 N Street NW
Washington, District of Columbia 20036
United States
- Firm Profile
- Go to...
Gregory Demske
Position
Partner
Career
Greg Demske is a partner in Goodwin’s Complex Litigation & Dispute Resolution (CL&DR) and Healthcare practices. He provides strategic compliance counseling for healthcare and life sciences companies. Greg helps clients achieve their business goals while reducing risks under the Anti-Kickback Statute, False Claims Act, and other fraud and abuse authorities in business arrangements and transactions. He advises on developing and operating compliance programs, requesting advisory opinions, anticipating and addressing compliance issues, submitting voluntary disclosures, and responding to government investigations and enforcement actions.
Prior to joining Goodwin, Greg served as Chief Counsel to the Inspector General, Department of Health and Human Services (HHS), where he led the provision of all legal services and advice for the HHS Office of Inspector General (OIG).
Education
JD 1990 The Ohio State University Michael E. Moritz College of Law; BS 1986 Miami University
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation